Why Laboratory Corporation of America Holdings (NYSE:LH) Is In News?


Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $143.13 on Laboratory Corporation of America Holdings (NYSE:LH) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $8.79 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Laboratory Corporation of America Holdings (NYSE:LH) stands at 23.64. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Laboratory Corporation of Ameri, the PEG ratio for coming 3-5 years is 1.54. Technical Analysis The technical analysis highlights that Laboratory Corporation of Ameri current price is trading $6.26 points away +4.81% from $130.01, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $119.76 and, for now, the stock price is trading $16.51 or +13.78% away from that point. The 52-week high of Laboratory Corporation of America Holdings (NYSE:LH) was $137.48 while lowest point recorded in 52-week was $97.79. It implies if stock price makes a movement of over $-1.21, it will record a new 52-week high. In the case of $+39.35% points drop, it will touch a new 52-week low.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 12 times, 1 visits today)